Molecular and phylogenetic analysis of the HPV 16 E4 gene in cervical lesions from women in Greece

Archives of Virology

Volumn 157, Issue 9, 2012, Pages 1729-1739

  Tsakogiannis, D ^a   Ruether, I G A ^a   Kyriakopoulou, Z ^a   Pliaka, V ^a   Skordas, V ^a   Gartzonika, C ^b   Levidiotou Stefanou, S ^b   Markoulatos, P ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOGENE PROTEIN E4, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; VIRUS DNA;

AMINO ACID SUBSTITUTION; ARTICLE; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; DNA SEQUENCE; FEMALE; GENETICS; GENOTYPE; GREECE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; ISOLATION AND PURIFICATION; MISSENSE MUTATION; MOLECULAR EPIDEMIOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PAPILLOMAVIRUS INFECTION; PHYLOGENY; VIROLOGY;

AMINO ACID SUBSTITUTION; CLUSTER ANALYSIS; DNA, VIRAL; FEMALE; GENOTYPE; GREECE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; SEQUENCE ANALYSIS, DNA;

HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 84865720463     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-012-1356-1     Document Type: Article

References (45)

1. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401: 70-79.
2. Sundström K, Eloranta S, Sparén P, Arnheim Dahlström L, Gunnell A, Lindgren A, Palmgren J et al (2010) Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix. Cancer Epidemiol Biomarkers Prev 19: 2469-2478.
3. Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE (2010) Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. Cancer Epidemiol Biomarkers Prev 19: 1675-1681.
4. Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S (2010) Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202: 1789-1799.
5. Kedzia W, Józefiak A, Pruski D, Rokita W, Marek S (2010) Human papilloma virus genotyping in women with CIN 1. Ginekol Pol 81: 664-667.
6. Tornesello ML, Losito S, Benincasa G, Fulciniti F, Botti G, Greggi S, Buonaguro L, Buonaguro FM (2011) Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix. Gynecol Oncol 121: 32-42.
7. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM (1997) Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71: 2463-2472.
8. Yamada T, Wheeler CM, Halpern AL, Stewart AC, Hildesheim A, Jenison SA (1995) Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol 69: 7743-7753.
9. Wheeler CM, Yamada T, Hildesheim A, Jenison SA (1997) Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol 35: 11-19.
10. Tsakogiannis D, Ruether IG, Kyriakopoulou Z, Pliaka V, Theoharopoulou A, Skordas V, Panotopoulou E, Nepka C, Markoulatos P (2012) Sequence variation analysis of the E2 gene of human papilloma virus type 16 in cervical lesions from women in Greece. Arch Virol. doi: 10. 1007/s00705-012-1236-8.
11. Swan DC, Rajeevan M, Tortolero-Luna G, Follen M, Tucker RA, Unger ER (2005) Human papillomavirus type 16 E2 and E6/E7 variants. Gynecol Oncol 96: 695-700.
12. Eriksson A, Herron JR, Yamada T, Wheeler CM (1999) Human papillomavirus type 16 variant lineages characterised by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region. J Gen Virol 80: 595-600.
13. Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, Villa LL (2007) High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer 120: 1763-1768.
14. Sanchez GI, Kleter B, Gheit T, van Doorn LJ, de Koning MN, de Sanjosé S et al (2011) Clinical evaluation of polymerase chain reaction reverse hybridization assay for detection and identification of human papillomavirus type 16 variants. J Clin Virol 51: 165-169.
15. Tornesello ML, Losito S, Benincasa G, Fulciniti F, Botti G, Greggi S et al (2011) Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix. Gynecol Oncol 121: 32-42.
16. Lehoux M, D'Abramo CM, Archambault J (2009) Molecular mechanisms of human papillomavirus-induced carcinogenesis. Public Health Genomics. 12: 268-280.
17. Doorbar J (2007) Papillomavirus life cycle organization and biomarker selection. Dis Markers 23: 297-313.
18. Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ (2006) HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol 208: 152-164.
19. Münger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens M, Grace M, Huh K (2004) Mechanisms of human papillomavirus-induced oncogenesis. J Virol 78: 11451-11460.
20. Fehrmann F, Laimins LA (2003) Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 22: 5201-5207.
21. Schwartz S (2008) HPV-16 RNA processing. Front Biosci 13: 5880-5891.
22. Schwartz S, Zhao S, Öberg D, Rush M (2004) Regulation of papillomavirus late gene expression. Recent Res Dev Virol 6: 29-45.
23. Doorbar J, Foo C, Coleman N, Medcalf L, Hartley O, Prospero T et al (1997) Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4. Virology 238: 40-52.
24. Middleton K, Peh W, Southern S, Griffin H, Sotlar K, Nakahara T et al (2003) Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J Virol 77: 10186-10201.
25. Chow LT, Broker TR (2007) Human papillomavirus RNA transcription. In: Garcea RL, DiMaio D (eds) The Papillomaviruses. Springer, New York, pp 109-144.
26. Howley PM (1996) Papillomavirinae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM (eds) Fields virology, 3rd edn. Lippincott-Raven, Philadelphia, pp 2045-2076.
27. McIntosh PB, Laskey P, Sullivan K, Davy C, Wang Q, Jackson DJ, Griffin HM, Doorbar J (2010) E1-E4-mediated keratin phosphorylation and ubiquitylation: a mechanism for keratin depletion in HPV16-infected epithelium. J Cell Sci 123: 2810-2822.
28. Davy CE, Jackson DJ, Wang Q, Raj K, Masterson PJ, Fenner NF et al (2002) Identification of a G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16. J Virol 76: 9806-9818.
29. Davy CE, Jackson DJ, Raj K, Peh WL, Southern SA, Das P, Sorathia R et al (2005) Human papillomavirus type 16 E1 E4-induced G2 arrest is associated with cytoplasmic retention of active Cdk1/cyclin B1 complexes. J Virol 79: 3998-4011.
30. Roberts S, Kingsbury SR, Stoeber K, Knight GL, Gallimore PH, Williams GH (2008) Identification of an arginine-rich motif in human papillomavirus type 1 E1; E4 protein necessary for E4-mediated inhibition of cellular DNA synthesis in vitro and in cells. J Virol 82: 9056-9064.
31. Davy C, McIntosh P, Jackson DJ, Sorathia R, Miell M, Wang Q, Khan J, Soneji Y, Doorbar J (2009) A novel interaction between the human papillomavirus type 16 E2 and E1-E4 proteins leads to stabilization of E2. Virology 394: 266-275.
32. Casas I, Powell L, Klapper PE, Cleator GM (1995) New method for the extraction of viral RNA and DNA from cerebrospinal fluid for use in the polymerase chain reaction assay. J Virol Methods 53: 25-36.
33. Puranen M, Saarikoski S, Syrjänen K, Syrjänen S (1996) Polymerase chain reaction amplification of human papillomavirus DNA from archival, Papanicolaou-stained cervical smears. Acta Cytol 40: 391-395.
34. Sotlar K, Diemer D, Dethleffs A, Hack Y et al (2004) Detection and typing of human papillomavirus by E6 nested multiplex PCR. J Clin Microbiol 42: 3176-3184.
35. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4. 0. Mol Biol Evol 24: 1596-1599.
36. Edgar RC (2004) MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32: 1792-1797.
37. Pond SL, Frost SD (2005) Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics 21: 2531-2533.
38. Suzuki Y, Gojobori T (1999) A method for detecting positive selection at single amino acid sites. Mol Biol Evol 16: 1315-1328.
39. Drummond AJ, Rambaut A (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7: 214.
40. Doorbar, J and Myers G (1996) The E4 protein. In: Myers HDG, Icenogelet J (eds) Human papillomaviruses, vol. 3. Los Alamos National Laboratory, Los Alamos, NM, pp 58-80.
41. Eriksson A, Herron JR, Yamada T, Wheeler CM (1999) Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region. J Gen Virol 80: 595-600.
42. Roberts S, Ashmole I, Gibson LJ, Rookes SM, Barton GJ, Gallimore PH (1994) Mutational analysis of human papillomavirus E4 proteins: identification of structural features important in the formation of cytoplasmic E4/cytokeratin networks in epithelial cells. J Virol 68: 6432-6445.
43. Wang Q, Griffin H, Southern S, Jackson D, Martin A et al (2004) Functional analysis of the human papillomavirus type 16 E1=E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization. J Virol 78: 821-833.
44. Hughes AL, Hughes MA (2005) Patterns of nucleotide difference in overlapping and non-overlapping reading frames of papillomavirus genomes. Virus Res 113: 81-88.
45. Burk RD, Chen Z, van Doorslaer K (2009) Human papillomaviruses: genetic basis of carcinogenicity. Public Health Genomics 12: 281-290.